SEC Form 4/A · accession 0001644348-15-000001
HALOZYME THERAPEUTICS, INC. · HALO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Laurie Stelzer
Officer — Chief Financial Officer
Period of report
Aug 20, 2015
Accepted (ET)
Aug 26, 2015 · 2:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001159036
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 20, 2015 | P | 10,000 | $17.2384 | A | 10,000 | I | By trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This amendment is being filed to correct a typographical error contained in footnote (1) of the original filing. Although the transaction was correctly reported in Table I, the footnote incorrectly indicated that shares were sold in multiple transactions. The footnote should correctly read as follows: The price reported is the average weighted price. The shares were purchased in multiple transactions at prices ranging from $17.21 to $17.25, inclusive. The reporting person undertakes to provide to the SEC, the issuer and any security holder full information regarding the number of shares and the prices at which the shares were purchased. Pursuant to previous SEC staff guidance, the previously reported transaction in Table I of the original filing is included in this amendment solely to permit this amendment to be filed.
- F2The reporting person is co-trustee of The Gregory and Laureen Stelzer Living Trust.